{
    "nct_id": "NCT06549478",
    "official_title": "A Pilot Study of BgRT for Bone Metastases",
    "inclusion_criteria": "* Documented informed consent of the participant and/or legally authorized representative\n\n  * Assent, when appropriate, will be obtained per institutional guidelines\n* Age: ≥ 18 years\n* Eastern Cooperative Oncology Group (ECOG) performance status 0-2\n* Pathologic diagnosis of cancer\n* Painful bone metastases from any solid cancers (i.e., a score of at least 2 on a 0-10 scale, 0 representing no pain and 10 representing maximum pain)\n* Concurrent treatment of up to 3 radiation fields is allowed\n* Standardized uptake value maximum (SUVmax) of the target bone lesions on diagnostic PET > 6\n* Size of the target bone lesion 1.5-5 cm\n* Pre-screening assessment confirms that the intervention can be administered without exceeding dose constraint guidelines\n* Patients with brain metastases can be included but brain metastases must be treated prior to enrollment and follow up magnetic resonance imaging (MRI) 3 months after treatment shows stable findings\n* Life expectancy ≥ 6 months in the opinion of the treating investigators\n* Off systemic therapy for at least one week prior and one week after study intervention\n* Patients able to complete pain assessment and quality of life surveys who do not have cognitive impairment\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Patients with prior radiation therapy to the treatment sites\n* Untreated spinal cord compression\n* Pathologic fracture at the evaluated site\n* Serious medical comorbidities precluding radiotherapy\n* Unable to undergo a PET/CT scan\n* Pregnant and/or breastfeeding women are excluded from this study as these agents may have the potential for teratogenic or abortifacient effects\n* Judgement by the investigator that the patient is unsuitable to participate in the study and the patient is unlikely to comply with study procedures, restrictions, and requirements\n* Prospective participants who, in the opinion of the investigator, may not be able to comply with all study procedures (including compliance issues related to feasibility/logistics, patients who exhibit cognitive impairments/ who are unable to complete study materials: assessments/questionnaires)",
    "miscellaneous_criteria": ""
}